The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour

© Alamy/PA
The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour

© Alamy/PA
Academics have hailed an ‘important advancement’ in type 2 diabetes care

© Getty/iStock
An estimated 2.4 million people are taking weight-loss drugs in the UK, with most of them accessing treatment privately

© Alamy/PA
An estimated 2.4 million people are taking weight-loss drugs in the UK, with most of them accessing treatment privately

© Alamy/PA